Pujade-Lauraine, E., Selle, F., Scambia, G., Asselain, B., Marmé, F., Lindemann, K., . . . investigators, O. (2023). Maintenance olaparib rechallenge in patients with platinum-sensitive relapsed ovarian cancer previously treated with a PARP inhibitor (OReO/ENGOT-ov38). Annals of oncology : official journal of the European Society for Medical Oncology, 34(12), p. 1152. doi:10.1016/j.annonc.2023.09.3110
Chicago ZitierstilPujade-Lauraine, E., et al. "Maintenance Olaparib Rechallenge in Patients With Platinum-sensitive Relapsed Ovarian Cancer Previously Treated With a PARP Inhibitor (OReO/ENGOT-ov38)." Annals of Oncology : Official Journal of the European Society for Medical Oncology 34, no. 12 (2023): 1152.
MLA ZitierstilPujade-Lauraine, E., et al. "Maintenance Olaparib Rechallenge in Patients With Platinum-sensitive Relapsed Ovarian Cancer Previously Treated With a PARP Inhibitor (OReO/ENGOT-ov38)." Annals of Oncology : Official Journal of the European Society for Medical Oncology 34.12 (2023): 1152.